SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-19-129301
Filing Date
2019-04-30
Accepted
2019-04-30 16:08:56
Documents
7
Effectiveness Date
2019-04-30

Document Format Files

Seq Description Document Type Size
1 DEFA14A d623378ddefa14a.htm DEFA14A 30828
2 GRAPHIC g623378g05e15.jpg GRAPHIC 23408
3 GRAPHIC g623378g16q56.jpg GRAPHIC 13701
4 GRAPHIC g623378g48k66.jpg GRAPHIC 28639
5 GRAPHIC g623378g62d05.jpg GRAPHIC 24728
6 GRAPHIC g623378g76c99.jpg GRAPHIC 32714
7 GRAPHIC g623378g87n84.jpg GRAPHIC 13084
  Complete submission text file 0001193125-19-129301.txt   220112
Mailing Address 80 GUEST STREET 5TH FLOOR BOSTON MA 02135
Business Address 80 GUEST STREET 5TH FLOOR BOSTON MA 02135 617-225-0096
PROTEOSTASIS THERAPEUTICS, INC. (Filer) CIK: 0001445283 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: DEFA14A | Act: 34 | File No.: 001-37695 | Film No.: 19781744
SIC: 2834 Pharmaceutical Preparations